A randomized prospective controlled trial of antibiotic prophylaxis in intraoral bone-grafting procedures: preoperative single-dose penicillin versus preoperative single-dose clindamycin.

In this comparative study, 150 consecutive patients undergoing local intraoral bone grafting randomly received either an oral single dose of 600 mg clindamycin or 2 g of the penicillin phenethicillin 1 h before incision. Primary endpoint was wound infection at the receptor site within 8 weeks of surgery. Secondary outcome measurements included postoperative infections at the donor site and adverse events as a result of antibiotic administration. Mean age of the patients was 36.8+/-12.7 years (range 18-67 years), and 98 patients were females (65.3%) and 52 males (34.7%). Infections at the receptor site were seen in 4 patients (5.3%; 95% CI 0.23-10.4%) of the phenethicillin group and in 2 patients (2.7%; 95% CI 0-6.36%) of the clindamycin group. In both groups, 3 patients had an infection at the donor site. Postoperative infections were predominantly caused by alpha-haemolytic Streptococci sensitive to penicillin. No significant difference was found between prophylactic single doses of phenethicillin and clindamycin with regard to postoperative infection in patients undergoing local bone augmentation procedures.
AuthorsJ A Lindeboom, J W Frenken, J G Tuk, F H Kroon
JournalInternational journal of oral and maxillofacial surgery (Int J Oral Maxillofac Surg) Vol. 35 Issue 5 Pg. 433-6 (May 2006) ISSN: 0901-5027 [Print] Denmark
PMID16472987 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Anti-Bacterial Agents
  • Clindamycin
  • phenethicillin
  • Penicillin V
  • Adolescent
  • Adult
  • Aged
  • Alveolar Ridge Augmentation
  • Anti-Bacterial Agents (administration & dosage)
  • Antibiotic Prophylaxis (methods)
  • Bone Transplantation
  • Clindamycin (administration & dosage)
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Maxilla (surgery)
  • Middle Aged
  • Penicillin V (administration & dosage, analogs & derivatives)
  • Prospective Studies
  • Surgical Wound Infection (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: